The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Haemochromatosis
Open accessAbstract
Haemochromatosis is defined as systemic iron overload of genetic origin, caused by a reduction in the concentration of the iron regulatory hormone hepcidin, or a reduction in hepcidin-ferroportin binding. Hepcidin regulates the activity of ferroportin, which is the only identified cellular iron exporter. The most common form of haemochromatosis is due to homozygous mutations (specifically, the C282Y mutation) in HFE, which encodes hereditary haemochromatosis protein. Non-HFE forms of haemochromatosis due to mutations in HAMP, HJV or TFR2 are much rarer. Mutations in SLC40A1 (also known as FPN1; encoding ferroportin) that prevent hepcidin-ferroportin binding also cause haemochromatosis. Cellular iron excess in HFE and non-HFE forms of haemochromatosis is caused by increased concentrations of plasma iron, which can lead to the accumulation of iron in parenchymal cells, particularly hepatocytes, pancreatic cells and cardiomyocytes. Diagnosis is noninvasive and includes clinical examination, assessment of plasma iron parameters, imaging and genetic testing. The mainstay therapy is phlebotomy, although iron chelation can be used in some patients. Hepcidin supplementation might be an innovative future approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Specific point mutations in the HFE gene, which encodes a major histocompatibility complex (MHC) class I-like molecule, are the cause of classical hereditary hemochromatosis (HH), the most prevalent IO disorder in subjects of Caucasian ancestry (Brissot et al., 2018).”
From Iron in infection and immunity (2020) · cites this paper as Brissot et al., 2018
Experimental — accuracy not yet measuredIn the citing paper
“Overall hemochromatosis is due to “insufficient hepcidin production” or exceptionally to “hepcidin resistance”.77”
From Iron metabolism and iron disorders revisited in the hepcidin era (2020) · cites this paper as [77]
In the citing paper
“Both genetic and acquired modifiers contribute to the penetrance of HFE-hemochromatosis, interfering with hepcidin expression: e.g., alcohol aggravates the iron burden, whereas blood donations attenuates it.77”
From Iron metabolism and iron disorders revisited in the hepcidin era (2020) · cites this paper as [77]
In the citing paper
“NTBI leads to the generation of reactive oxygen species and cell damage, causing liver fibrosis (which may progress to cirrhosis and hepatocellular carcinoma), chronic heart failure, diabetes, hypopituitarism and other complications of iron loading.77,79”
From Iron metabolism and iron disorders revisited in the hepcidin era (2020) · cites this paper as [77]
In the citing paper
“Transferrin saturation (Tsat), i.e. the ratio of serum iron/total iron binding capacity and serum ferritin coupled with genetic testing and non-invasive magnetic resonance imaging measurements of liver iron content, define the nature and severity of iron loading in both hemochromatosis77 and thalassemia.110”
From Iron metabolism and iron disorders revisited in the hepcidin era (2020) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Ware, J. E. (2000) · Spine · doi:10.1097/00007632-200012150-00008 · Cited by 4,455
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Cloning and characterization of a mammalian proton-coupled metal-ion transporter
Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., Nussberger, S., Gollan, J. L., & Hediger, M. A. (1997) · Nature · doi:10.1038/41343 · Cited by 3,166
The ferritins: molecular properties, iron storage function and cellular regulation
Harrison, P. M., & Arosio, P. (1996) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(96)00022-9 · Cited by 2,667
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
Self-citationPositional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000) · Nature · doi:10.1038/35001596 · Cited by 1,667
McKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T. J., Farzaneh, F., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80425-6 · Cited by 1,422
Flagged first, then by citations
Research works printed but not linked: 2
- Strachan, A. Haemosiderosis and haemochromatosis in South African natives with a comment on etiology of haemochrmatosis. Thesis, Univ. Glasgow (1929).
- Ware, J. et al. User's Manual for the SF36v2 Health Survey 2nd edn (QualityMetric, Lincoln RI, 2007).
Cited by
Sorted by citations
Iron homeostasis and oxidative stress: An intimate relationship
Galaris, D., Barbouti, A., & Pantopoulos, K. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.118535 · Cited by 960
Iron metabolism and iron disorders revisited in the hepcidin era
Camaschella, C., Nai, A., & Silvestri, L. (2020) · Haematologica · doi:10.3324/haematol.2019.232124 · Cited by 734
Iron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects
Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01969-z · Cited by 724
Non-invasive assessment of hepatic iron stores by MRI
Gandon, Y., Olivié, D., Guyader, D., Aubé, C., Oberti, F., Sebille, V., & Deugnier, Y. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15436-6 · Cited by 668
Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases
Song, X., & Long, D. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00267 · Cited by 586
Iron in infection and immunity
Nairz, M., & Weiss, G. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100864 · Cited by 359
Ferroptosis in health and disease
Berndt, C., Alborzinia, H., Skafar, V., Ayton, S., Barayeu, U., Bartelt, A., Bayır, H., Bebber, C. M., Birsoy, K., Böttcher, J. P., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103211 · Cited by 372
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Hwang, S. Y., Danpanichkul, P., Agopian, V. G., Mehta, N., Parikh, N. D., Abou‐Alfa, G. K., Singal, A. G., & Yang, J. D. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0824 · Cited by 359
ACG Clinical Guideline: Hereditary Hemochromatosis
Kowdley, K. V., Brown, K. E., Ahn, J. C., & Sundaram, V. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000315 · Cited by 294
A role of PIEZO1 in iron metabolism in mice and humans
Ma, S., Dubin, A. E., Zhang, Y., Mousavi, S. A. R., Wang, Y., Coombs, A. M., Loud, M., Andolfo, I., & Patapoutian, A. (2021) · Cell · doi:10.1016/j.cell.2021.01.024 · Cited by 232
Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis
Gao, H., Jin, Z., Bandyopadhyay, G., Wang, G., Zhang, D., Rocha, K. C. E., Liu, X., Zhao, H., Kisseleva, T., Brenner, D. A., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.07.006 · Cited by 224
EASL Clinical Practice Guidelines on haemochromatosis
Zoller, H., Schaefer, B., Vanclooster, A., Griffiths, B., Bardou‐Jacquet, E., Corradini, E., Porto, G., Ryan, J. D., & Cornberg, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.03.033 · Cited by 222
Schwartz, A. J., Das, N. K., Ramakrishnan, S. K., Jain, C., Jurkovic, M. T., Wu, J., Nemeth, E., Lakhal-Littleton, S., Colacino, J. A., & Shah, Y. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci122359 · Cited by 203
Alves, F. M., Lane, D. J. R., Nguyen, T. P. M., Bush, A. I., & Ayton, S. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02088-5 · Cited by 212
Hemochromatosis classification: update and recommendations by the BIOIRON Society
Girelli, D., Busti, F., Brissot, P., Cabantchik, I. Z., Muckenthaler, M. U., & Porto, G. (2021) · Blood · doi:10.1182/blood.2021011338 · Cited by 196
Self-citationNi, Z., Li, Y., Song, D., Ding, J., Mei, S., Sun, S., Cheng, W., Yu, J., Zhou, L., Kuang, Y., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05037-8 · Cited by 187
Inherited iron overload disorders
Piperno, A., Pelucchi, S., & Mariani, R. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.11.15 · Cited by 156
Hepcidin and the BMP-SMAD pathway: An unexpected liaison
Silvestri, L., Nai, A., Dulja, A., & Pagani, A. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.004 · Cited by 136
Fillebeen, C., Charlebois, E., Wagner, J., Katsarou, A., Mui, J., Vali, H., Garcia‐Santos, D., Ponka, P., Presley, J. F., & Pantopoulos, K. (2018) · Blood · doi:10.1182/blood-2018-05-850404 · Cited by 124
Frtús, A., Smolková, B., Uzhytchak, M., Lunová, M., Jirsa, M., Kubinová, Š., Dejneka, A., & Lunov, O. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.036 · Cited by 119
Katsarou, A., & Pantopoulos, K. (2018) · Pharmaceuticals · doi:10.3390/ph11040127 · Cited by 115
Oxidants and Antioxidants in the Redox Biochemistry of Human Red Blood Cells
Möller, M. N., Orrico, F., Villar, S. F., López, A. C., Silva, N., Donzé, M., Thomson, L., & Denicola, A. (2022) · ACS Omega · doi:10.1021/acsomega.2c06768 · Cited by 123
Quercetin attenuates neurotoxicity induced by iron oxide nanoparticles
Bardestani, A., Ebrahimpour, S., Esmaeili, A., & Esmaeili, A. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01059-0 · Cited by 106
Inherited Disorders of Iron Overload
Pantopoulos, K. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00103 · Cited by 101
Ehsani, S. (2020) · Biology Direct · doi:10.1186/s13062-020-00275-2 · Cited by 89
Moris, D., Martinino, A., Schiltz, S., Allen, P. J., Barbas, A. S., Sudan, D. L., King, L. Y., Berg, C. L., Kim, C., Bashir, M. R., et al. (2025) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.70018 · Cited by 96
Topiwala, A., Wang, C., Ebmeier, K. P., Burgess, S., Bell, S., Levey, D. F., Zhou, H., McCracken, C., Roca‐Fernández, A., Petersen, S. E., et al. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1004039 · Cited by 79
Pathophysiology and classification of iron overload diseases; update 2018
Brissot, P., Troadec, M., Loréal, O., & Brissot, É. (2018) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2018.08.006 · Cited by 82
Self-citationOlynyk, J. K., & Ramm, G. A. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2119758 · Cited by 84
NCOA4 is Regulated by HIF and Mediates Mobilization of Murine Hepatic Iron Stores After Blood Loss
Li, X., Lozovatsky, L., Sukumaran, A., Gonzalez, L. A., Jain, A., Liu, D., Ayala‐Lopez, N., & Finberg, K. E. (2020) · Blood · doi:10.1182/blood.2020006321 · Cited by 75
Cai, J., Zhang, M., Liu, Y., Li, H., Shang, L., Xu, T., Chen, Z., Wang, F., Qiao, T., & Li, K. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00500-5 · Cited by 78
Erythrocytes as a preferential target of oxidative stress in blood
Fujii, J., Homma, T., Kobayashi, S., Warang, P. P., Madkaikar, M. R., & Mukherjee, M. B. (2021) · Free Radical Research · doi:10.1080/10715762.2021.1873318 · Cited by 85
X-ray fluorescence microscopy methods for biological tissues
Pushie, M. J., Sylvain, N. J., Hou, H., Hackett, M. J., Kelly, M., & Webb, S. M. (2022) · Metallomics · doi:10.1093/mtomcs/mfac032 · Cited by 76
The role of regulated necrosis in endocrine diseases
Tonnus, W., Belavgeni, A., Beuschlein, F., Eisenhofer, G., Faßnacht, M., Kroiß, M., Krone, N. P., Reincke, M., Bornstein, S. R., & Linkermann, A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00499-w · Cited by 74
Ethnic Differences in Iron Status
Kang, W., Barad, A., Clark, A. G., Wang, Y., Xu, L., Gu, Z., & O'Brien, K. O. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab035 · Cited by 76
Kayani, K. F., Shatery, O. B. A., Mustafa, M. S., Alshatteri, A. H., Mohammed, S. J., & Aziz, S. B. (2024) · RSC Advances · doi:10.1039/d3ra08680a · Cited by 71
Iron and liver cancer: an inseparable connection
Hino, K., Yanatori, I., Hara, Y., & Nishina, S. (2021) · FEBS Journal · doi:10.1111/febs.16208 · Cited by 68
Armitage, A. E., & Moretti, D. (2019) · Pharmaceuticals · doi:10.3390/ph12020059 · Cited by 76
Ferroptosis and Its Potential Role in the Nervous System Diseases
Zhou, Y., Lin, W., Rao, T., Zheng, J., Zhang, T., Zhang, M., & Lin, Z. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s351799 · Cited by 70
Metal Ion Signaling in Biomedicine
Rodriguez, R., Müller, S., Colombeau, L., Solier, S., Sindikubwabo, F., & Cañeque, T. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00577 · Cited by 67
α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload
Camiolo, G., Tibullo, D., Giallongo, C., Romano, A., Parrinello, N. L., Musumeci, G., Rosa, M. D., Vicario, N., Brundo, M. V., Amenta, F., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030609 · Cited by 66
Pathology of Hepatic Iron Overload
Salomao, M. A. (2021) · Clinical Liver Disease · doi:10.1002/cld.1051 · Cited by 65
Genetic iron overload disorders
Corradini, E., Buzzetti, E., & Pietrangelo, A. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100896 · Cited by 64
Self-citationRevisiting hemochromatosis: genetic vs. phenotypic manifestations
Anderson, G. J., & Bardou‐Jacquet, E. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-5512 · Cited by 68
Jasiecki, J., Targońska, M., & Wasąg, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042033 · Cited by 67
Iron and Ferritin Modulate MHC Class I Expression and NK Cell Recognition
Sottile, R., Federico, G., Garofalo, C., Tallerico, R., Faniello, M. C., Quaresima, B., Cristiani, C. M., Sanzo, M. D., Cuda, G., Ventura, V., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00224 · Cited by 65
Iron and platelets: A subtle, under‐recognized relationship
Brissot, É., Troadec, M., Loréal, O., & Brissot, P. (2021) · American Journal of Hematology · doi:10.1002/ajh.26189 · Cited by 60
Self-citationDai, C., Kong, B., Qin, T., Xiao, Z., Fang, J., Gong, Y., Zhu, J., Liu, Q., Fu, H., Meng, H., et al. (2021) · Toxicology · doi:10.1016/j.tox.2021.153055 · Cited by 59
SLC40A1 in iron metabolism, ferroptosis, and disease: A review
Zhang, Y., Zou, L., Li, X., Guo, L., Hu, B., Ye, H., & Liu, Y. (2024) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1644 · Cited by 64
The Space of Disse: The Liver Hub in Health and Disease
Sanz-García, C., Fernández-Iglesias, A., Gracia-Sancho, J., Arráez-Aybar, L. A., Nevzorova, Y. A., & Cubero, F. J. (2021) · Livers · doi:10.3390/livers1010002 · Cited by 57
Alcohol Exposure Induces Depressive and Anxiety-like Behaviors via Activating Ferroptosis in Mice
Xu, C., Xiong, Q., Tian, X., Liu, W., Sun, B., Ru, Q., & Shu, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213828 · Cited by 56
Xiao, Q., & Lauschke, V. M. (2021) · npj Genomic Medicine · doi:10.1038/s41525-021-00203-x · Cited by 53
Gong, F., Zheng, X., Xu, W., Xie, R., Liu, W., Pei, L., Zhong, M., Shi, W., Qu, H., Mao, E., et al. (2025) · MedComm · doi:10.1002/mco2.70049 · Cited by 58
Gallo, P., Terracciani, F., Pasquale, G. D., Esposito, M., Picardi, A., & Gentilucci, U. V. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i30.4061 · Cited by 49
Liver Iron Loading in Alcohol-Associated Liver Disease
Ali, N., Ferrao, K., & Mehta, K. J. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.08.010 · Cited by 49
Demetz, E., Tymoszuk, P., Hilbe, R., Volani, C., Haschka, D., Heim, C., Auer, K., Lener, D., Zeiger, L. B., Pfeifhofer‐Obermair, C., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa140 · Cited by 47
Iron at the Interface of Hepatocellular Carcinoma
Paganoni, R., Lechel, A., & Spasić, M. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084097 · Cited by 48
Iron overload promotes Cyclin D1 expression and alters cell cycle in mouse hepatocytes
Troadec, M., Courselaud, B., Détivaud, L., Haziza‐Pigeon, C., Leroyer, P., Brissot, P., & Loréal, O. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.07.033 · Cited by 47
Self-citationRole of Iron in the Molecular Pathogenesis of Diseases and Therapeutic Opportunities
Abbasi, U., Abbina, S., Gill, A., Takuechi, L. E., & Kizhakkedathu, J. N. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00122 · Cited by 48
Ferroptosis: mechanisms and advances in ocular diseases
Liu, K., Li, H., Wang, F., & Su, Y. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04644-5 · Cited by 47
Managing the Dual Nature of Iron to Preserve Health
Silvestri, L., Pettinato, M., Furiosi, V., Volpe, L. B., Nai, A., & Pagani, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043995 · Cited by 49
Fatty infiltration of the pancreas: a systematic concept analysis
Mahyoub, M. A., Elhoumed, M., Maqul, A. H., Almezgagi, M., Abbas, M. A., Jiao, Y., Wang, J., Alnaggar, M., Zhao, P., & He, S. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1227188 · Cited by 43
Li, X., Xie, E., Sun, S., Shen, J., Ding, Y., Wang, J., Peng, X., Zheng, R., Farag, M. A. F., & Xiao, J. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.01.014 · Cited by 48
Wang, C., Xiao, X., Bayer, A. L., Xu, Y., Dev, S., Canali, S., Nair, A. V., Masia, R., & Babitt, J. L. (2019) · Hepatology · doi:10.1002/hep.30780 · Cited by 47
Diagnosis and management of hereditary haemochromatosis
Murphree, C. R., Nguyen, N., Raghunathan, V. M., Olson, S. R., DeLoughery, T. G., & Shatzel, J. J. (2020) · Vox Sanguinis · doi:10.1111/vox.12896 · Cited by 45
Lin, H., Zhou, Y., Wang, J., Wang, H., Yao, T., Chen, H., Zheng, H., Zhang, Y., Ren, E., Jiang, L., et al. (2021) · Science Advances · doi:10.1126/sciadv.abl5862 · Cited by 46
Sachdeva, V., Monga, A., Vashisht, R., Singh, D., Singh, A., & Bedi, N. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103585 · Cited by 45
The cardinal roles of ferroportin and its partners in controlling cellular iron in and out
Yang, Q., Liu, W., Zhang, S., & Liu, S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118135 · Cited by 48
The Emerging Role of Ferroptosis in Sepsis
Liu, Y., Tan, S., Wu, Y., & Tan, S. (2022) · DNA and Cell Biology · doi:10.1089/dna.2021.1072 · Cited by 46
Kowdley, K. V., Modi, N. B., Peltekian, K. M., Vierling, J. M., Ferris, C. D., Valone, F. H., & Gupta, S. (2023) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00250-9 · Cited by 42
Boyer, É., Gall‐David, S. L., Martin, B., Fong, S. B., Loréal, O., Deugnier, Y., Bonnaure‐Mallet, M., & Meuric, V. (2018) · Scientific Reports · doi:10.1038/s41598-018-33813-0 · Cited by 42
Self-citationMetabolic Signature of Dietary Iron Overload in a Mouse Model
Volani, C., Paglia, G., Smarason, S., Pramstaller, P. P., Demetz, E., Pfeifhofer‐Obermair, C., & Weiß, G. (2018) · Cells · doi:10.3390/cells7120264 · Cited by 40
Liu, Z., Simchick, G. A., Qiao, J., Ashcraft, M. M., Cui, S., Nagy, T., Zhao, Q. C., & Xiong, M. P. (2020) · ACS Nano · doi:10.1021/acsnano.0c01083 · Cited by 39
Metabolic Disorders and Anesthesia
Yeoh, C. B., Teng, H. C., Jackson, J., Hingula, L. P., Irie, T., Legler, A., Levine, C., Chu, I., Chai, C. M., & Tollinche, L. E. (2019) · Current anesthesiology reports · doi:10.1007/s40140-019-00345-w · Cited by 38
Fisher, A. L., & Babitt, J. L. (2021) · Developmental Dynamics · doi:10.1002/dvdy.372 · Cited by 41
Mohan, M., Mannan, A., Kakkar, C., & Singh, T. G. (2024) · Current Drug Targets · doi:10.2174/0113894501320839240918110656 · Cited by 37
Wang, X., Zhang, M., Woloshun, R. R., Yu, Y., Lee, J. K., Flores, S. R., Merlin, D., & Collins, J. F. (2021) · Nutrients · doi:10.3390/nu13051686 · Cited by 37
Iron effects versus metabolic alterations in hereditary hemochromatosis driven bone loss
Baschant, U., Altamura, S., Steele-Perkins, P., Muckenthaler, M. U., Spasić, M. V., Hofbauer, L. C., Steinbicker, A. U., & Rauner, M. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.06.004 · Cited by 37
Iron Absorption: Molecular and Pathophysiological Aspects
Correnti, M., Gammella, E., Cairo, G., & Recalcati, S. (2024) · Metabolites · doi:10.3390/metabo14040228 · Cited by 48
Neutrophils from hereditary hemochromatosis patients are protected from iron excess and are primed
Renassia, C., Louis, S., Cuvellier, S., Boussetta, N., Deschemin, J., Borderie, D., Bailly, K., Poupon, J., Dang, P. M., Benna, J. E., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020002198 · Cited by 35
Zhang, L., Song, Y., Cao, K., Du, Y., Han, M., Shi, Z., Yan, F., & Feng, S. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202107195 · Cited by 35
Teschke, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052668 · Cited by 34
Altamura, S., Schaeper, U., Dames, S., Löffler, K., Eisermann, M., Frauendorf, C., Müdder, K., Neves, J., & Muckenthaler, M. U. (2019) · HemaSphere · doi:10.1097/hs9.0000000000000301 · Cited by 34
Food‐borne polyphenols: A biocompatible anchor recuperating iron homeostasis
Li, Y., Feng, X., Zheng, X., Zhu, J., & Gu, Q. (2023) · Food Frontiers · doi:10.1002/fft2.244 · Cited by 32
Varman, G. A., Kalanidhi, K., & Nagaraaj, P. (2022) · Dyes and Pigments · doi:10.1016/j.dyepig.2022.110101 · Cited by 32
Secondary Iron Overload and the Liver: A Comprehensive Review
Pinyopornpanish, K., Tantiworawit, A., Leerapun, A., Soontornpun, A., & Thongsawat, S. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00420 · Cited by 32
Meghdadi, S., Khodaverdian, N., Amirnasr, A., French, P. J., van Royen, M. E., Wiemer, E. A. C., & Amirnasr, M. (2019) · Journal of Photochemistry and Photobiology A Chemistry · doi:10.1016/j.jphotochem.2019.112193 · Cited by 32
Hemochromatosis after the gene discovery: revisiting the diagnostic strategy
Brissot, P., Moirand, R., Guyader, D., Loréal, O., Turlin, B., & Deugnier, Y. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80369-3 · Cited by 30
Self-citationLiu, J., Liu, W., Liu, Y., Miao, Y., Guo, Y., Song, H., Wang, F., Zhou, H., Ganz, T., Yan, B., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.209874 · Cited by 30
Daniłowicz‐Szymanowicz, L., Świątczak, M., Sikorska, K., Starzyński, R. R., Raczak, A., & Lipiński, P. (2021) · Diagnostics · doi:10.3390/diagnostics11071279 · Cited by 32
Too much iron: A masked foe for leukemias
Brissot, É., Bernard, D. G., Loréal, O., Brissot, P., & Troadec, M. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100617 · Cited by 29
Self-citationJulián‐Serrano, S., Yuan, F., Wheeler, W., Benyamin, B., Machiela, M. J., Arslan, A. A., Freeman, L. E. B., Bracci, P. M., Duell, E. J., Du, M., et al. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab217 · Cited by 29
Moksnes, M. R., Hansen, A. F., Wolford, B. N., Thomas, L. F., Rasheed, H., Simić, A., Bhatta, L., Brantsæter, A. L., Surakka, I. L., Zhou, W., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06101-z · Cited by 31
The Role of Iron in Benign and Malignant Hematopoiesis
Sinha, S., Pereira-Reis, J., Guerra, A., Rivella, S., & Duarte, D. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8155 · Cited by 29
Liu, C., Chen, Y., Zhang, Z., Xie, J., Yu, C., Xu, L., & Li, Y. (2022) · Nutrients · doi:10.3390/nu14245237 · Cited by 28
Troadec, M., Glaise, D., Lamirault, G., Cunff, M. L., Guérin, É., Meur, N. L., Détivaud, L., Zindy, P. J., Leroyer, P., Guisle, I., et al. (2005) · Genomics · doi:10.1016/j.ygeno.2005.08.016 · Cited by 27
Self-citationSecondary iron overload induces chronic pancreatitis and ferroptosis of acinar cells in mice
Tian, C., Zhao, J., Xiong, Q., Yu, H. J., & Du, H. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5212 · Cited by 26
Hepatic SEL1L-HRD1 ER-associated degradation regulates systemic iron homeostasis via ceruloplasmin
Thepsuwan, P., Bhattacharya, A., Song, Z., Hippleheuser, S. W., Feng, S., Wei, X., Das, N. K., Sierra, M., Wei, J., Fang, D., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2212644120 · Cited by 26
Butler‐Laporte, G., Farjoun, Y., Chen, Y., Hultström, M., Liang, K. Y. H., Nakanishi, T., Su, C., Yoshiji, S., Forgetta, V., & Richards, J. B. (2023) · International Journal of Epidemiology · doi:10.1093/ije/dyad010 · Cited by 27
Lévesque, J.-P., SUMMERS, K. M., Bisht, K., Millard, S. M., Winkler, I. G., & Pettit, A. R. (2021) · Experimental Hematology · doi:10.1016/j.exphem.2021.08.011 · Cited by 26
Metadata
- Authors
- Brissot, P., Pietrangelo, A., Adams, P. C., de Graaff, B., McLaren, C. E., & Loréal, O.
- Affiliations
- Inserm (FR)
- Azienda Ospedaliero-Universitaria di Modena (IT)
- Western University (CA)
- University of California, Irvine (US)
- Corresponding author
- Brissot, Pierre
- Venue
- Nature Reviews Disease Primers
- Published
- 2018-04-05
- Volume
- 4
- Issue
- 1
- Pages
- 18016-18016
- ISSN
- 2056-676X (ISSN-L)
- PMC
- PMC7775623
- OpenAlex
- W4232013301
- Cited by
- 430
- References
- 223
- Citations by year
- 2026: 35 · 2025: 44 · 2024: 64 · 2023: 54 · 2022: 74 · 2021: 69 · 2020: 42 · 2019: 24 · 2018: 11
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- Locations
- Nature Reviews Disease Primers (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eCite Digital Repository (University of Tasmania) (submittedVersion)
- UTAS Research Repository (submittedVersion)
- HAL (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Funders
- National Cancer Institute (P30CA062203)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- hemochromatosis, iron overload, hepcidin, ferroportin, HFE C282Y mutation, hemojuvelin, transferrin receptor 2, SLC40A1, iron metabolism, phlebotomy, iron chelation, diagnosis, clinical management, quality of life
- MeSH terms
- Ferroportin, Hemochromatosis, Humans, Iron, Magnetic Resonance Imaging, Mass Screening, Polymorphism, Genetic, Quality of Life, Chelation Therapy, Phlebotomy, Cation Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
